Operating Lease, Right-of-Use Asset of Sunshine Biopharma Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sunshine Biopharma Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Sunshine Biopharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $820,489, a 52% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sunshine Biopharma Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $820,489 +$279,021 +52% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $892,817 +$328,897 +58% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $900,890 +$300,642 +50% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $936,037 +$289,258 +45% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $541,468 -$122,828 -18% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $563,920 -$147,139 -21% 30 Jun 2024 10-Q/A 20 Aug 2024 2024 Q2
Q1 2024 $600,248 -$127,881 -18% 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 $646,779 -$113,630 -15% 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 $664,296 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $711,059 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $728,129 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $760,409 +$760,409 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $0 31 Dec 2021 10-K 04 Apr 2023 2022 FY
Q1 2019 $95,610 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 20 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.